Bernd R. Seizinger - 16 Jan 2026 Form 4 Insider Report for ONCOLYTICS BIOTECH INC (ONCY)

Role: Director
Signature: /s/ Kirk Look, Attorney-in-Fact
Issuer symbol: ONCY
Transactions as of: 16 Jan 2026
Net transactions value: +$103,770
Form type: 4
Filing time: 20 Jan 2026, 16:30:18 UTC
Previous filing: 02 Jan 2026
Next filing: 13 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Seizinger Bernd R.	Director	C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO	/s/ Kirk Look, Attorney-in-Fact	20 Jan 2026	0001789042

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONCY	Common Shares	Purchase	$103,770	+100,000	+27%	$1.04	466,991	16 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0294 to $1.0499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0294 to $1.0499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.